Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 344
Filtrar
1.
Vive (El Alto) ; 7(20): 438-450, ago. 2024.
Artigo em Espanhol | LILACS | ID: biblio-1568511

RESUMO

Introducción: Existe una conexión bidireccional entre mecanismos fisiológicos del intestino y la piel que puede asociarse al desarrollo de patologias cutâneas. Objetivo: estudiar la relación entre afecciones cutáneas con la presencia de patógenos intestinales causantes de disbiosis intestinal. Metodología: se realizó un estudio para identificar la presencia de bacterias aeróbicas y anaeróbicas facultativas en un grupo de 45 pacientes (edad de 32,8 ± 18 años) que presentaron distintas afecciones cutáneas diagnosticadas en la consulta de Dermatología de UNIMEL, Caracas, Venezuela. La presencia de bacterias se determinó por cultivo diferencial, y la identificación de microorganismos mediante pruebas bioquímicas convencionales, prueba de filamentización en suero, medios automatizados (VITEK® 2 Compact) y pruebas de aglutinación. Se realizó un análisis estadístico descriptivo de la abundancia relativa de la microbiota gastrointestinal asociada a las afecciones cutáneas presentes (GraphPad Prism versión 8.0.2 para Windows) y análisis multivariado (NMDS) con (software PAST v4.13). Resultados: la presencia de acné, dermatitis atópica y nevus se asoció (p<0.05) al aumento de las colonias de Enterococcus faecium, E. coli, Enteroccocus faecalis y Klepsiella sp. Una disminución significativa en el número de colonias de E. coli (p<0.05) se asoció con la presencia de rosácea y acné inflamatorio mientras que su abundancia se asoció a la presencia de patologías como acantosis nigicans, dermatitis atópica, dermatitis papular y queratosis. La presencia de pseudomonas se relacionó con queratosis y Nevus melanocítico. Conclusión: aunque preliminares, estos resultados sugieren que alteraciones en la composición microbiana intestinal pueden asociarse significativamente a afecciones cutáneas


Introduction: There is a bidirectional connection between physiological mechanisms of the intestine and the skin that can be associated with the development of skin pathologies. Objective: To study the relationship between skin conditions with the presence of intestinal pathogens that cause intestinal dysbiosis. Methodology: a study was carried out to identify the presence of aerobic and facultative anaerobic bacteria in a group of 45 patients (age 32.8 ± 18 years) who presented different skin conditions diagnosed in the Dermatology clinic of UNIMEL, Caracas, Venezuela. The presence of bacteria was determined by differential culture, and the identification of microorganisms by conventional biochemical tests, serum filamentation test, automated media (VITEK® 2 Compact) and agglutination tests. A descriptive statistical analysis of the relative abundance of the gastrointestinal microbiota associated with the present skin conditions was performed (GraphPad Prism version 8.0.2 for Windows) and multivariate analysis (NMDS) with (PAST v4.13 software). Results: the presence of acne, atopic dermatitis and nevus was associated (p<0.05) with the increase in colonies of Enterococcus faecium, E. coli, Enteroccocus faecalis and Klepsiella sp. A significant decrease in the number of E. coli colonies (p<0.05) was associated with the presence of rosacea and inflammatory acne while its abundance was associated with the presence of pathologies such as acanthosis nigicans, atopic dermatitis, papular dermatitis and keratosis. The presence of pseudomonas was related to keratosis and melanocytic nevus. Conclusion: although preliminary, these results suggest that alterations in intestinal microbial composition can be significantly associated with skin conditions.


Introdução: existe uma ligação bidirecional entre mecanismos fisiológicos do intestino e da pele que pode estar associada ao desenvolvimento de patologias cutâneas. Objetivo: estudar a relação entre as condições da pele com a presença de patógenos intestinais causadores de disbiose intestinal. Metodologia: foi realizado um estudo para identificar a presença de bactérias aeróbias e anaeróbias facultativas em um grupo de 45 pacientes (idade 32,8 ± 18 años) que apresentavam diferentes condições de pele diagnosticadas na clínica de Dermatologia da UNIMEL, Caracas, Venezuela. A presença de bactérias foi determinada por cultura diferencial, e a identificação de microrganismos por testes bioquímicos convencionais, teste de filamentação sérica, meios automatizados (VITEK® 2 Compact) e testes de aglutinação. Foi realizada análise estatística descritiva da abundância relativa da microbiota gastrointestinal associada às presentes condições de pele (GraphPad Prism versão 8.0.2 para Windows) e análise multivariada (NMDS) com (software PAST v4.13). Resultados: A presença de acne, dermatite atópica e nevo esteve associada (p<0,05) ao aumento de colônias de Enterococcus faecium, E. coli, Enteroccocus faecalis e Klepsiella sp. Uma diminuição significativa no número de colônias de E. coli (p<0,05) foi associada à presença de rosácea e acne inflamatória, enquanto sua abundância foi associada à presença de patologias como acantose nigicans, dermatite atópica, dermatite papular e ceratose. A presença de pseudomonas foi relacionada à ceratose e ao nevo melanocítico. Conclusão: embora preliminares, estes resultados sugerem que alterações na composição microbiana intestinal podem estar significativamente associadas a doenças da pele.

2.
Vive (El Alto) ; 7(20)ago. 2024.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1570115

RESUMO

Introducción: Existe una conexión bidireccional entre mecanismos fisiológicos del intestino y la piel que puede asociarse al desarrollo de patologias cutâneas. Objetivo: Estudiar la relación entre afecciones cutáneas con la presencia de patógenos intestinales causantes de disbiosis intestinal. Metodología: Se realizó un estudio para identificar la presencia de bacterias aeróbicas y anaeróbicas facultativas en un grupo de 45 pacientes (edad de 32,8 ± 18 años) que presentaron distintas afecciones cutáneas diagnosticadas en la consulta de Dermatología de UNIMEL, Caracas, Venezuela. La presencia de bacterias se determinó por cultivo diferencial, y la identificación de microorganismos mediante pruebas bioquímicas convencionales, prueba de filamentización en suero, medios automatizados (VITEK® 2 Compact) y pruebas de aglutinación. Se realizó un análisis estadístico descriptivo de la abundancia relativa de la microbiota gastrointestinal asociada a las afecciones cutáneas presentes (GraphPad Prism versión 8.0.2 para Windows) y análisis multivariado (NMDS) con (software PAST v4.13). Resultados: La presencia de acné, dermatitis atópica y nevus se asoció (p<0.05) al aumento de las colonias de Enterococcus faecium, E. coli, Enteroccocus faecalis y Klepsiella sp. Una disminución significativa en el número de colonias de E. coli (p<0.05) se asoció con la presencia de rosácea y acné inflamatorio mientras que su abundancia se asoció a la presencia de patologías como acantosis nigicans, dermatitis atópica, dermatitis papular y queratosis. La presencia de pseudomonas se relacionó con queratosis y Nevus melanocítico. Conclusión: Aunque preliminares, estos resultados sugieren que alteraciones en la composición microbiana intestinal pueden asociarse significativamente a afecciones cutáneas.


Introduction: There is a bidirectional connection between physiological mechanisms of the intestine and the skin that can be associated with the development of skin pathologies. Objective: To study the relationship between skin conditions with the presence of intestinal pathogens that cause intestinal dysbiosis. Methodology: A study was carried out to identify the presence of aerobic and facultative anaerobic bacteria in a group of 45 patients (age 32.8 ± 18 years) who presented different skin conditions diagnosed in the Dermatology clinic of UNIMEL, Caracas, Venezuela. The presence of bacteria was determined by differential culture, and the identification of microorganisms by conventional biochemical tests, serum filamentation test, automated media (VITEK® 2 Compact) and agglutination tests. A descriptive statistical analysis of the relative abundance of the gastrointestinal microbiota associated with the present skin conditions was performed (GraphPad Prism version 8.0.2 for Windows) and multivariate analysis (NMDS) with (PAST v4.13 software). Results: The presence of acne, atopic dermatitis and nevus was associated (p<0.05) with the increase in colonies of Enterococcus faecium, E. coli, Enteroccocus faecalis and Klepsiella sp. A significant decrease in the number of E. coli colonies (p<0.05) was associated with the presence of rosacea and inflammatory acne while its abundance was associated with the presence of pathologies such as acanthosis nigicans, atopic dermatitis, papular dermatitis and keratosis. The presence of pseudomonas was related to keratosis and melanocytic nevus. Conclusion: Although preliminary, these results suggest that alterations in intestinal microbial composition can be significantly associated with skin conditions.


Introdução: Existe uma ligação bidirecional entre mecanismos fisiológicos do intestino e da pele que pode estar associada ao desenvolvimento de patologias cutâneas. Objetivo: Estudar a relação entre as condições da pele com a presença de patógenos intestinais causadores de disbiose intestinal. Metodologia: Foi realizado um estudo para identificar a presença de bactérias aeróbias e anaeróbias facultativas em um grupo de 45 pacientes (idade 32,8 ± 18 años) que apresentavam diferentes condições de pele diagnosticadas na clínica de Dermatologia da UNIMEL, Caracas, Venezuela. A presença de bactérias foi determinada por cultura diferencial, e a identificação de microrganismos por testes bioquímicos convencionais, teste de filamentação sérica, meios automatizados (VITEK® 2 Compact) e testes de aglutinação. Foi realizada análise estatística descritiva da abundância relativa da microbiota gastrointestinal associada às presentes condições de pele (GraphPad Prism versão 8.0.2 para Windows) e análise multivariada (NMDS) com (software PAST v4.13). Resultados: A presença de acne, dermatite atópica e nevo esteve associada (p<0,05) ao aumento de colônias de Enterococcus faecium, E. coli, Enteroccocus faecalis e Klepsiella sp. Uma diminuição significativa no número de colônias de E. coli (p<0,05) foi associada à presença de rosácea e acne inflamatória, enquanto sua abundância foi associada à presença de patologias como acantose nigicans, dermatite atópica, dermatite papular e ceratose. A presença de pseudomonas foi relacionada à ceratose e ao nevo melanocítico. Conclusão: Embora preliminares, estes resultados sugerem que alterações na composição microbiana intestinal podem estar significativamente associadas a doenças da pele.

3.
Microbiome ; 12(1): 145, 2024 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-39107803

RESUMO

BACKGROUND: This study aimed to engineer and optimise a dysbiotic biofilm model to develop in vitro root caries for investigating microbial modulation strategies. The model involved growing complex biofilms from a saliva inoculum collected from four volunteers using two strategies. In the first strategy ("pre-treatment strategy"), bovine root slabs were used, and two natural compounds were incorporated at time 0 of the 10-day biofilm experiment, which included sucrose cycles mimicking the cariogenic environment. In the second strategy ("post-treatment strategy"), mature biofilms were grown in a modified Calgary biofilm device coated with collagen and hydroxyapatite for 7 days and then were exposed to the same natural compounds. The metatranscriptome of each biofilm was then determined and analysed. Collagenase activity was examined, and the biofilms and dentine were imaged using confocal and scanning electron microscopy (SEM). Mineral loss and lesion formation were confirmed through micro-computed tomography (µ-CT). RESULTS: The pH confirmed the cariogenic condition. In the metatranscriptome, we achieved a biofilm compositional complexity, showing a great diversity of the metabolically active microbiome in both pre- and post-treatment strategies, including reads mapped to microorganisms other than bacteria, such as archaea and viruses. Carbohydrate esterases had increased expression in the post-treated biofilms and in samples without sugar cycles, while glucosyltransferases were highly expressed in the presence of sucrose cycles. Enrichment for functions related to nitrogen compound metabolism and organic cyclic component metabolism in groups without sucrose compared to the sucrose-treated group. Pre-treatment of the roots with cranberry reduced microbial viability and gelatinase (but not collagenase) activity (p < 0.05). SEM images showed the complexity of biofilms was maintained, with a thick extracellular polysaccharides layer. CONCLUSIONS: This root caries model was optimized to produce complex cariogenic biofilms and root caries-like lesions, and could be used to test microbial modulation in vitro. Pre-treatments before biofilm development and cariogenic challenges were more effective than post-treatments. The clinical significance lies in the potential to apply the findings to develop varnish products for post-professional tooth prophylaxis, aiming at implementing a strategy for dysbiosis reversal in translational research. Video Abstract.


Assuntos
Biofilmes , Microbiota , Cárie Radicular , Saliva , Humanos , Cárie Radicular/microbiologia , Saliva/microbiologia , Bovinos , Animais , Bactérias/genética , Bactérias/isolamento & purificação , Dentina/microbiologia , Colagenases/metabolismo
4.
Mol Neurobiol ; 2024 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-39120823

RESUMO

Human microbiota is known to influence immune and cerebral responses by direct and/or indirect mechanisms, including hypothalamic-pituitary-adrenal axis signaling, activation of neural afferent circuits to the brain, and by altering the peripheral immune responses (cellular and humoral immune function, circulatory inflammatory cells, and the production of several inflammatory mediators, such as cytokines, chemokines, and reactive oxygen species). The inflammatory responses in the nasal mucosa (rhinitis) or paranasal sinuses (chronic rhinosinusitis) are dual conditions related with a greater risk for developing depression. In the nasal cavity, anatomic components of the olfactive function are in direct contact with the CNS through the olfactory receptors, neurons, and axons that end in the olfactory bulb and the entorhinal cortex. Local microbiome alterations (dysbiosis) are linked to transepithelial translocation of microorganisms and their metabolites, which disrupts the epithelial barrier and favors vascular permeability, increasing the levels of several inflammatory molecules (both cytokines and non-cytokine mediators: extracellular vesicles (exosomes) and neuropeptides), triggering local inflammation (rhinitis) and the spread of these components into the central nervous system (neuroinflammation). In this review, we discuss the role of microbiota-related immunity in conditions affecting the nasal mucosa (chronic rhinosinusitis and allergic rhinitis) and their relevance in major depressive disorders, focusing on the few mechanisms known to be involved and providing some hypothetical proposals on the pathophysiology of depression.

5.
Int J Mol Sci ; 25(13)2024 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-39000013

RESUMO

Obesity is a global health concern implicated in numerous chronic degenerative diseases, including type 2 diabetes, dyslipidemia, and neurodegenerative disorders. It is characterized by chronic low-grade inflammation, gut microbiota dysbiosis, insulin resistance, glucose intolerance, and lipid metabolism disturbances. Here, we investigated the therapeutic potential of environmental enrichment (EE) to prevent the progression of gut dysbiosis in mice with high-fat diet (HFD)-induced metabolic syndrome. C57BL/6 male mice with obesity and metabolic syndrome, continuously fed with an HFD, were exposed to EE. We analyzed the gut microbiota of the mice by sequencing the 16s rRNA gene at different intervals, including on day 0 and 12 and 24 weeks after EE exposure. Fasting glucose levels, glucose tolerance, insulin resistance, food intake, weight gain, lipid profile, hepatic steatosis, and inflammatory mediators were evaluated in serum, adipose tissue, and the colon. We demonstrate that EE intervention prevents the progression of HFD-induced dysbiosis, reducing taxa associated with metabolic syndrome (Tepidimicrobium, Acidaminobacteraceae, and Fusibacter) while promoting those linked to healthy physiology (Syntrophococcus sucrumutans, Dehalobacterium, Prevotella, and Butyricimonas). Furthermore, EE enhances intestinal barrier integrity, increases mucin-producing goblet cell population, and upregulates Muc2 expression in the colon. These alterations correlate with reduced systemic lipopolysaccharide levels and attenuated colon inflammation, resulting in normalized glucose metabolism, diminished adipose tissue inflammation, reduced liver steatosis, improved lipid profiles, and a significant reduction in body weight gain despite mice's continued HFD consumption. Our findings highlight EE as a promising anti-inflammatory strategy for managing obesity-related metabolic dysregulation and suggest its potential in developing probiotics targeting EE-modulated microbial taxa.


Assuntos
Dieta Hiperlipídica , Disbiose , Microbioma Gastrointestinal , Camundongos Endogâmicos C57BL , Obesidade , Animais , Dieta Hiperlipídica/efeitos adversos , Disbiose/microbiologia , Camundongos , Obesidade/metabolismo , Obesidade/microbiologia , Masculino , Glucose/metabolismo , Camundongos Obesos , Resistência à Insulina , Síndrome Metabólica/metabolismo , Síndrome Metabólica/etiologia , Síndrome Metabólica/microbiologia
6.
Hipertens Riesgo Vasc ; 41(3): 145-153, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38871574

RESUMO

BACKGROUND: The COVID-19 pandemic has highlighted the vulnerability of particular patient groups to SARS-CoV-2 infection, including those with cardiovascular diseases, hypertension, and intestinal dysbiosis. COVID-19 affects the gut, suggesting diet and vitamin D3 supplementation may affect disease progression. AIMS: To evaluate levels of Ang II and Ang-(1-7), cytokine profile, and gut microbiota status in patients hospitalized for mild COVID-19 with a history of cardiovascular disease and treated with daily doses of vitamin D3. METHODS: We recruited 50 adult patients. We screened 50 adult patients and accessed pathophysiology study 22, randomized to daily oral doses of 10,000IU vitamin D3 (n=11) or placebo (n=11). Plasma levels of Ang II and Ang-(1-7) were determined by radioimmunoassay, TMA and TMAO were measured by liquid chromatography and interleukins (ILs) 6, 8, 10 and TNF-α by ELISA. RESULTS: The Ang-(1-7)/Ang II ratio, as an indirect measure of ACE2 enzymatic activity, increased in the vitamin D3 group (24±5pg/mL vs. 4.66±2pg/mL, p<0.01). Also, in the vitamin D3-treated, there was a significant decline in inflammatory ILs and an increase in protective markers, such as a substantial reduction in TMAO (5±2µmoles/dL vs. 60±10µmoles/dL, p<0.01). In addition, treated patients experienced less severity of infection, required less intensive care, had fewer days of hospitalization, and a reduced mortality rate. Additionally, improvements in markers of cardiovascular function were seen in the vitamin D3 group, including a tendency for reductions in blood pressure in hypertensive patients. CONCLUSIONS: Vitamin D3 supplementation in patients with COVID-19 and specific conditions is associated with a more favourable prognosis, suggesting therapeutic potential in patients with comorbidities such as cardiovascular disease and gut dysbiosis.


Assuntos
COVID-19 , Doenças Cardiovasculares , Colecalciferol , Suplementos Nutricionais , Disbiose , Microbioma Gastrointestinal , Fragmentos de Peptídeos , Humanos , Colecalciferol/administração & dosagem , Masculino , Feminino , Doenças Cardiovasculares/prevenção & controle , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/epidemiologia , Pessoa de Meia-Idade , COVID-19/complicações , Fragmentos de Peptídeos/sangue , Idoso , Angiotensina I/sangue , Angiotensina II/sangue , Tratamento Farmacológico da COVID-19 , Vitaminas/administração & dosagem , Metilaminas/sangue , Citocinas/sangue , Enzima de Conversão de Angiotensina 2/metabolismo , SARS-CoV-2 , Método Duplo-Cego
7.
Biochem Pharmacol ; 226: 116363, 2024 08.
Artigo em Inglês | MEDLINE | ID: mdl-38871336

RESUMO

Helminth infections, which affect approximately 1.5 billion individuals worldwide (mainly children), are common in low- and middle-income tropical countries and can lead to various diseases. One crucial factor affecting the occurrence of these diseases is the reduced diversity of the gut microbiome due to antibiotic use. This reduced diversity compromises immune health in hosts and alters host gene expression through epigenetic mechanisms. Helminth infections may produce complex biochemical signatures that could serve as therapeutic targets. Such therapies include next-generation probiotics, live biotherapeutic products, and biochemical drug approaches. Probiotics can bind ferric hydroxide, reducing the iron that is available to opportunistic microorganisms. They also produce short-chain fatty acids associated with immune response modulation, oral tolerance facilitation, and inflammation reduction. In this review, we examine the potential link between these effects and epigenetic changes in immune response-related genes by analyzing methyltransferase-related genes within probiotic strains discussed in the literature. The identified genes were only correlated with methylation in bacterial genes. Various metabolic interactions among hosts, helminth parasites, and intestinal microbiomes can impact the immune system, potentially aiding or hindering worm expulsion through chemical signaling. Implementing a comprehensive strategy using probiotics may reduce the impact of drug-resistant helminth strains.


Assuntos
Países em Desenvolvimento , Microbioma Gastrointestinal , Helmintíase , Probióticos , Probióticos/uso terapêutico , Probióticos/administração & dosagem , Helmintíase/imunologia , Helmintíase/prevenção & controle , Humanos , Animais , Microbioma Gastrointestinal/fisiologia , Microbioma Gastrointestinal/efeitos dos fármacos , Epigênese Genética/efeitos dos fármacos
8.
Metab Brain Dis ; 39(5): 967-984, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38848023

RESUMO

The aging of populations is a global phenomenon that follows a possible increase in the incidence of neurodegenerative diseases. Alzheimer's, Parkinson's, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Huntington's diseases are some neurodegenerative disorders that aging could initiate or aggravate. Recent research has indicated that intestinal microbiota dysbiosis can trigger metabolism and brain functioning, contributing to the etiopathogenesis of those neurodegenerative diseases. The intestinal microbiota and its metabolites show significant functions in various aspects, such as the immune system modulation (development and maturation), the maintenance of the intestinal barrier integrity, the modulation of neuromuscular functions in the intestine, and the facilitation of essential metabolic processes for both the microbiota and humans. The primary evidence supporting the connection between intestinal microbiota and its metabolites with neurodegenerative diseases are epidemiological observations and animal models experimentation. This paper reviews up-to-date evidence on the correlation between the microbiota-gut-brain axis and neurodegenerative diseases, with a specially focus on gut metabolites. Dysbiosis can increase inflammatory cytokines and bacterial metabolites, altering intestinal and blood-brain barrier permeability and causing neuroinflammation, thus facilitating the pathogenesis of neurodegenerative diseases. Clinical data supporting this evidence still needs to be improved. Most of the works found are descriptive and associated with the presence of phyla or species of bacteria with neurodegenerative diseases. Despite the limitations of recent research, the potential for elucidating clinical questions that have thus far eluded clarification within prevailing pathophysiological frameworks of health and disease is promising through investigation of the interplay between the host and microbiota.


Assuntos
Eixo Encéfalo-Intestino , Disbiose , Microbioma Gastrointestinal , Doenças Neurodegenerativas , Humanos , Microbioma Gastrointestinal/fisiologia , Doenças Neurodegenerativas/metabolismo , Doenças Neurodegenerativas/microbiologia , Disbiose/metabolismo , Eixo Encéfalo-Intestino/fisiologia , Animais , Barreira Hematoencefálica/metabolismo , Encéfalo/metabolismo
9.
Am J Primatol ; 86(8): e23654, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38922738

RESUMO

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization in March 2020. Since then, viral spread from humans to animals has occurred worldwide. Nonhuman primates (NHPs) have been found to be susceptible to reverse-zoonosis transmission of SARS-CoV-2, but initial research suggested that platyrrhine primates are less susceptible than catarrhine primates. Here we report the natural SARS-CoV-2 infection of a common woolly monkey (Lagothrix lagothricha) from a wildlife rehabilitation center in Ecuador. The course of the disease, the eventual death of the specimen, and the pathological findings are described. Our results show the susceptibility of a new platyrrhine species to SARS-CoV-2 and provide evidence for the first time of a COVID-19-associated death in a naturally infected NHP. The putative route of transmission from humans, and implications for captive NHPs management, are also discussed. Given that common woolly monkeys are at risk of extinction in Ecuador, further understanding of the potential threat of SARS-CoV-2 to their health should be a conservation priority. A One Health approach is the best way to protect NHPs from a new virus in the same way that we would protect the human population.


Assuntos
Atelinae , COVID-19 , Doenças dos Macacos , SARS-CoV-2 , Animais , COVID-19/veterinária , COVID-19/mortalidade , COVID-19/transmissão , Atelinae/virologia , Equador/epidemiologia , Doenças dos Macacos/virologia , Evolução Fatal , Masculino , Feminino
10.
Int Microbiol ; 2024 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-38844735

RESUMO

BACKGROUND: Probiotic bacteria inhibit aggregation, biofilm formation, and dimorphism of Candida spp. However, the effects of a new probiotic, Streptococcus dentisani, on the growth of Candida albicans and Candida glabrata biofilms are unknown. OBJECTIVE: To determine the effect of S. dentisani on the different phases of C. albicans and C. glabrata biofilm development. METHODS: Growth quantification and ultrastructural analyses were performed on biofilms of C. albicans ATCC 90028, C. glabrata ATCC 2001, and clinical isolates of C. albicans from oral candidiasis (CA-C1), caries (CA-CR1), and periodontal pocket (CA-P1) treated with cell suspensions of S. dentisani CECT 7746. Cell viability was determined by quantifying colony-forming units (CFU/mL). The ultrastructural analyses were done with atomic force microscopy. RESULTS: S. dentisani induced a significant reduction (p < 0.05) of CFU/mL of immature and mature biofilm in all strains of C. albicans and C. glabrata. Microscopic analysis revealed that S. dentisani reduced C. albicans density in mixed biofilm. The fungus-bacteria interaction affected cell membrane integrity in yeast. CONCLUSION: For the first time, our data elucidate the antifungal effect of S. dentisani on the development of C. albicans and C. glabrata biofilms, supporting its usefulness as a niche-specific probiotic to prevent and treat oral dysbiosis.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA